Effects of prosthetic treatment for shortened dental arches on oral health-related quality of life, self-reports of pain and jaw disability: results from the pilot-phase of a randomized multicentre trial

A multi‐centre randomized clinical trial is under way at 14 university dental schools in Germany to compare prosthodontic treatments for the shortened dental arch (SDA). One of the aims of this pilot‐study was to measure the effect of two treatment options of the SDA on oral health‐related quality of life and on the Research Diagnostic Criteria (RDC) for temporomandibular disorders (TMD). Thirty‐four patients participated in the pilot‐study. Inclusion criteria were: all molars were missing and the presence of at least both canines and one premolar in each quadrant. Participants were randomly assigned to receive either removable partial dentures including molar replacement (RPD_group) or retain a premolar occlusion (PROC_group). The Oral Health Impact Profile (OHIP‐49) and the RDC for TMD were completed by participants before treatment (pre‐treatment), 6 weeks (6wks), 6 months (6m) and 12 months (12m) after treatment. At the 12‐month follow up, data of 10 women and 11 men (mean age: 62 ± 10 years) were available. Medians of the OHIP total‐scores were as follows: RPD (n = 10), 43·5 (pre‐treatment), 18·2 (6wks), 13·3 (6m), 14·7 (12m). PROC (n = 11): 31·8 (pre‐treatment), 27·1 (6wks), 8·8 (6m), 8·3 (12m). Significant differences were shown for RPD_group between pre‐treatment and 6m/12m and for PROC_group between pre‐treatment and 6m. There were no significant differences between treatment groups at any time. Within each group, an improvement of life‐quality was observed. No significant difference could be reported between the two therapy concepts. This may be due to the low sample size within the pilot study.